GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3201 - 3225 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G78074HX
52
IgM Patient 3 -180 mild
G78074HX
80
IgA Patient 3 4 mild
G78074HX
394
IgG Patient 3 11 mild
G78074HX
70
IgG Patient 3 4 mild
G78074HX
68
IgM Patient 3 11 mild
G78074HX
133
IgM Patient 3 4 mild
G78074HX
147
IgA Patient 4 12 mild
G78074HX
553
IgG Patient 4 12 mild
G78074HX
597
IgM Patient 4 12 mild
G78074HX
554
IgA Patient 1 10 moderate
G78255UI
444
IgA Patient 1 22 moderate
G78255UI
414
IgA Patient 1 6 moderate
G78255UI
446
IgG Patient 1 10 moderate
G78255UI
31
IgG Patient 1 22 moderate
G78255UI
40
IgM Patient 1 10 moderate
G78255UI
41
IgM Patient 1 22 moderate
G78255UI
147
IgG Patient 1 6 moderate
G78255UI
31
IgM Patient 1 6 moderate
G78255UI
39
IgA Patient 2 15 mild
G78255UI
647
IgA Patient 2 24 mild
G78255UI
633
IgG Patient 2 15 mild
G78255UI
511
IgG Patient 2 24 mild
G78255UI
310
IgM Patient 2 15 mild
G78255UI
418
IgM Patient 2 24 mild
G78255UI
362

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024